Vibostolimab coformulated with pembrolizumab (vibo/pembro) for previously treated advanced mismatch repair-deficient (dMMR) endometrial cancer: Results from cohort B1 of the phase 2 KEYVIBE-005 study

Rojas C., Eskens F., Ghiringhelli F., Ozguroglu M., Caglevic C., Gumus M., ...More

JOURNAL OF CLINICAL ONCOLOGY, no.16, 2024 (SCI-Expanded, Scopus) identifier

  • Publication Type: Article / Abstract
  • Publication Date: 2024
  • Journal Name: JOURNAL OF CLINICAL ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, PASCAL, CAB Abstracts, CINAHL, Gender Studies Database, International Pharmaceutical Abstracts, Veterinary Science Database
  • Istanbul University-Cerrahpasa Affiliated: No